A5044034621- Pancreatic and Hepatic Oncology Research
- Neuroendocrine Tumor Research Advances
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Neuropeptides and Animal Physiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Neuroblastoma Research and Treatments
- Pancreatitis Pathology and Treatment
- Cancer Genomics and Diagnostics
- Colorectal Cancer Surgical Treatments
- Peptidase Inhibition and Analysis
- Renal cell carcinoma treatment
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
- Pediatric Hepatobiliary Diseases and Treatments
- Gastric Cancer Management and Outcomes
- Augmented Reality Applications
- Colorectal and Anal Carcinomas
- Gallbladder and Bile Duct Disorders
- Cancer, Lipids, and Metabolism
- Colorectal Cancer Screening and Detection
- Cancer, Stress, Anesthesia, and Immune Response
- Multiple and Secondary Primary Cancers
- Adrenal and Paraganglionic Tumors
- Fire dynamics and safety research
Roswell Park Comprehensive Cancer Center
2013-2023
Erytech Pharma (France)
2018
Roche (Switzerland)
2018
BeiGene (China)
2018
Symphogen (Denmark)
2018
AbbVie (United States)
2018
Novartis (Switzerland)
2018
Ipsen (France)
2018
Engineering Associates (United States)
2018
Bristol-Myers Squibb (Switzerland)
2018
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, multiple endocrine neoplasia. NETs are generally subclassified by site origin, stage, histologic characteristics. Appropriate diagnosis treatment often involves collaboration between specialists disciplines, using specific biochemical,...
The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, paragangliomas. Management NETs relies heavily on site primary NET. These Insights summarize options 2018 updates to guidelines locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, thymus NETs.
Neuroendocrine tumors (NETs) comprise a broad family of that may or not be associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical Practice Guidelines in Oncology for Tumors discuss the diagnosis and management both sporadic hereditary NETs. This selection from guidelines focuses on NETs pancreas, gastrointestinal tract, lung, thymus.
In the year 2005, an estimated 31,800 people will die of pancreatic cancer in United States. This disease is fourth most common cause cancer-related death among men Its peak incidence occurs seventh and eighth decades life. Although roughly equal two sexes, African Americans appear to have a higher than white Americans. these NCCN Pancreatic Adenocarcinoma guidelines, only tumors exocrine pancreas are discussed; endocrine from islets Langerhans carcinoid not included. For recent version...
Neuroendocrine tumors comprise a broad family of tumors, the most common which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Tumors Guidelines discuss diagnosis management both sporadic hereditary Most recommendations pertain to well-differentiated, low- intermediate-grade This updated version includes new section on pathology for reporting revised surgical pancreas.
NCCN Categories of Evidence and ConsensusCategory 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) there uniform consensus.Category 2A: lowerlevel 2B: nonuniform consensus (but no major disagreement).Category 3: any level but reflects disagreement.All recommendations are category 2A unless otherwise noted.Clinical trials: believes that the best management for cancer patient in a clinical trial.Participation trials especially encouraged.
Abstract Twelve patients with irresectable or recurrent hilar cholangiocarcinoma were treated internal biliary drainage followed by intraluminal (iridium-192) and external-beam radiotherapy. Biliary was accomplished means of a combined surgical interventional radiological approach. Initial decompression performed surgically tumour resection, intrahepatic enteric bypass distal biliary-enteric anastomosis temporary stent. Maintenance application radiotherapy radiologically the use percutaneous...
Background There is limited literature about the clinicopathological characteristics and outcomes of rare histologic variants gallbladder cancer (GBC). Methods Using SEER database, surgically managed GBC patients with microscopically confirmed adenocarcinoma, adenosquamous/squamous cell carcinoma papillary were identified from 1988 to 2009. Patients second primary distant metastasis at presentation excluded. The effect variables on overall survival (OS) disease specific (DSS) analyzed using...
Objective This study determined whether there are any laboratory or other features that will enable prediction of spontaneous closure in patients with gastrointestinal cutaneous fistulas. Summary Background Data Although the anatomic criteria for fistulas have been presented by several authors, less than 50% such tend to close, even most recent series. Methods A group anatomical favorable were investigated respect a series parameters including usual demographic parameters, plus fistula...
We retrospectively analyzed the results of patients with locally advanced unresectable pancreatic cancer (LAPC) treated either chemoradiation (CRT) or chemotherapy alone over past decade.Between December 1998 and October 2009, 116 LAPC were at our institution. Eighty-four received concurrent [RT (+) group], primarily 5-flourouracil based (70%). Thirty-two (-) majority gemcitabine (78%). Progression-free survival (PFS) overall (OS) calculated from date diagnosis to first recurrence death last...
An estimated 5-10% of all pancreatic adenocarcinomas have a hereditary association. The objective the current study was to characterize clinical and pathologic features familial carcinoma determine potential differences in demographics, risk factors, outcomes between sporadic populations.A retrospective review performed identify patients diagnosed with who had an associated disposition. Demographic analyses assessment treatment were for subgroup, results compared observations made...
BACKGROUND Surgical site infections (SSIs) following colorectal surgery (CRS) are among the most common healthcare-associated (HAIs). Reduction in SSI rates is an important goal for surgical quality improvement. OBJECTIVE To examine of patients with and without cancer to identify potential predictors risk CRS DESIGN American College Surgeons National Quality Improvement Program (ACS NSQIP) data files 2011–2013 from a sample 12 Comprehensive Cancer Network (NCCN) member institutions were...
Changes in postsurgical opioid prescribing practices may help reduce chronic use surgical patients.